REQUEST A DEMO
Total
USD $0.00
Search more companies

Mg Pharma S.R.O. (Czech Republic)

Main Activities: Beer, Wine, and Liquor Stores | Department Stores
Secondary Activities: New Housing For-Sale Builders | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Restaurants and Other Eating Places
Full name: Mg Pharma S.R.O. Profile Updated: October 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mg Pharma S.R.O. is a company in Czech Republic, with a head office in Opava. The enterprise operates in the Beer, Wine, and Liquor Stores industry. It was established on September 16, 2002. It currently has a total number of 10 - 19 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 12.71% in 2024. Its’ total assets recorded a growth of 63.62%. The net profit margin of Mg Pharma S.R.O. increased by 10.9% in 2024.

Headquarters
Ostrozna 244/27
Opava; Moravskoslezsky; Postal Code: 74601

Contact Details: Purchase the Mg Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mg Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Mg Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Mg Pharma S.R.O. report to view the information.
Incorporation Date:
September 16, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mg Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
12.71%
Total operating revenue
12.86%
Operating profit (EBIT)
392.69%
EBITDA
197.84%
Net Profit (Loss) for the Period
1047.98%
Total assets
63.62%
Total equity
52.6%
Operating Profit Margin (ROS)
14.12%
Net Profit Margin
10.9%
Return on Equity (ROE)
29.88%
Debt to Equity Ratio
87.98%
Quick Ratio
-0.13%
Cash Ratio
0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?